文献速递湿疹皮炎与荨麻疹

成人特应性皮炎系统治疗患者决策辅助工具的研发

Development of a Patient Decision Aid for Atopic Dermatitis Systemic Treatments in Adults.
PubMed 文献 · JAMA Dermatol · 2026-01-01

本研究遵循国际患者决策辅助工具标准协作组织指南,通过定性研究分阶段开发了成人中重度特应性皮炎系统治疗的患者决策辅助工具。患者偏好简洁、透明的视觉格式和聚焦疗效、给药频率、途径、相关不良反应及费用,而临床医生更重视实验室监测、疗效和不良反应数据。最终工具采用分阶段方法平衡双方偏好,以促进医患共同决策。

要点

  • 患者决策辅助工具可帮助成人中重度特应性皮炎患者选择系统治疗。
  • 患者偏好简洁语言和疗效、给药、不良反应及费用等信息。
  • 临床医生更关注实验室监测、疗效和不良反应的详细数据。

核心结论

  • 开发了符合国际患者决策辅助工具标准协作组织指南的成人中重度特应性皮炎系统治疗患者决策辅助工具。
  • 患者决策辅助工具制定时应优先考虑简洁性以促进患者理解。
  • 分阶段方法可能有助于以患者为中心的方式传递复杂治疗信息,增强医患讨论并促进共享决策。

研究设计与样本

  • 定性研究,遵循国际患者决策辅助工具标准协作组织指南,于2020至2025年在俄勒冈健康与科学大学皮肤科进行。
  • 开发过程包括范围界定与设计、原型开发、α测试、β测试和最终定稿阶段。
  • 指导组包括10名成人中重度特应性皮炎患者和6名皮肤科临床医生用于原型开发,8名患者和5名临床医生用于α测试,5名患者和2名临床医生用于最终定稿。
  • β测试包括8名新患者和6名临床医生。

主要发现

  • 初始指导组10名患者平均年龄38.7岁(范围20-74岁),其中8名为女性。
  • 患者重视透明有序的视觉格式、简化语言以及聚焦疗效、给药频率、给药途径、相关不良反应和相对费用的内容主题。
  • 皮肤科临床医生优先考虑实验室监测、疗效和不良反应数据。
  • 患者偏好简洁,而临床医生偏好强调细节。

关键数值与推荐

  • 最终患者决策辅助工具符合国际患者决策辅助工具标准协作组织指南,采用分阶段方法平衡患者与临床医生的偏好。

临床怎么用

  • 该患者决策辅助工具可用于支持成人中重度特应性皮炎患者系统治疗选择中的医患讨论和共享决策。
  • 使用时应考虑分阶段呈现信息,以兼顾患者对简洁性和临床医生对细节的需求。

局限性

  • 本研究为定性研究,样本量较小,结果可能不适用于更广泛人群。
  • 研究在单一学术医疗中心进行,可能存在机构偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patient decision aids (PDAs) are tools that facilitate medical discourse between patients and clinicians, enabling patients to make informed choices among treatment options. While PDAs have been developed for other dermatologic conditions, to our knowledge, none exist for adults with atopic dermatitis (AD). OBJECTIVE: To develop a PDA that assists adult patients with moderate to severe AD in selecting systemic treatment options. DESIGN, SETTING, AND PARTICIPANTS: For this qualitative study, the PDA was developed per International Patient Decision Aid Standards Collaboration guidelines. The development process used a systematic approach following designated phases: scoping and design, prototype development, alpha testing, beta testing, and finalization. A steering group was used for all stages of development except for beta testing, which used participants outside of the steering group. The study was conducted from 2020 to 2025 at Oregon Health & Science University's Department of Dermatology in both in-person and virtual environments. The steering groups consisted of 10 adult patients with moderate to severe AD and 6 dermatology clinicians for prototype development, 8 patients and 5 clinicians for alpha testing, and 5 patients and 2 clinicians for finalization of the PDA (performed after beta testing, which included 8 new patients and 6 clinicians). MAIN OUTCOMES AND MEASURES: PDA content and quality assessments occurred through qualitative thematic analysis performed on open-ended feedback question responses from patients and clinicians. RESULTS: Among the 10 patients in the initial steering group, the mean (range) age was 38.7 (20-74) years, and 8 were female. Patients valued transparent and organized visual formatting, simplified language, and focused content themes, such as efficacy, dosing frequency, route of administration, relevant adverse effects, and relative costs. Dermatology clinicians prioritized laboratory monitoring, efficacy, and adverse effect data. Patients preferred simplicity, whereas clinicians preferred an emphasis on detail. The finalized International Patient Decision Aid Standards Collaboration-adherent PDA used a staged approach to balance these preferences. CONCLUSIONS AND RELEVANCE: This qualitative study supports prior findings that when formulating PDAs, authors should prioritize simplicity to enable patient comprehension in clinician-led discussions. This study found that a staged approach may help to deliver complex treatment information in a patient-centered manner, enhancing patient-clinician discussions, and facilitating shared decision-making in adults with AD.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Okereke R, Baghoomian W, Dunlap RR, et al. Development of a Patient Decision Aid for Atopic Dermatitis Systemic Treatments in Adults. JAMA Dermatol. 2026. PMID: 41670968. doi:10.1001/jamadermatol.2025.5912

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。